Michael Pulsipher Joins Children’s Hospital Los Angeles
01 July 2015 - 12:52PM
Business Wire
The renowned researcher will head the Blood and Marrow
Transplantation (BMT) section at CHLA, one of world’s largest
pediatric BMT programs
Michael Allen Pulsipher, MD, will join the Children’s Center for
Cancer and Blood Diseases and the Division of Hematology, Oncology
and Blood and Marrow Transplantation at Children’s Hospital Los
Angeles as head of the Section of Blood and Marrow Transplantation
(BMT) and as BMT clinical research chair, effective July 1, 2015.
In addition, Pulsipher will be a professor of Pediatrics at the
Keck School of Medicine of the University of Southern California
(USC) and a Member of the USC Norris Comprehensive Cancer
Center.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20150630006644/en/
Michael Allen Pulsipher, MD (Photo:
Business Wire)
The pediatric BMT Program at CHLA is one of the largest in the
world, having performed more than 1,300 transplants since 1983 for
a wide variety of pediatric disorders including malignant,
hematological, immunodeficiency and other diseases. In directing
the pediatric BMT program’s clinical care and clinical research
activities, Pulsipher will closely collaborate in the further
development of a leading research program that integrates
laboratory and clinical science toward the delivery of innovative
cell-based therapies.
“Children’s Hospital Los Angeles is very excited to have Dr.
Pulsipher join us in this important leadership position, as we work
to develop more effective and less toxic therapies for children
with cancer and blood diseases,” said Alan Wayne, MD, Director of
the Children’s Center for Cancer and Blood Diseases and Division
Head of Hematology, Oncology and Blood and Marrow Transplantation
at CHLA. “In addition to providing overall direction for our
transplantation program, his research expertise will bring
additional strength to our team of clinicians and scientists at
CHLA who are leading the fight against refractory childhood
leukemia.”
Pulsipher most recently served at Primary Children’s Hospital
and the University of Utah School of Medicine in Salt Lake City. He
earned his medical degree at Stanford University School of
Medicine, followed by residency training in pediatrics at
Children’s Hospital of Philadelphia and pediatric
hematology-oncology fellowship training at Boston Children’s
Hospital/Dana-Farber Cancer Institute. Among his many leadership
roles, Pulsipher has served as director of the Utah Blood and
Marrow Transplant Program, as medical director of the Utah Cord
Blood Program, and as current group chair of the Pediatric Blood
and Marrow Transplant Consortium – an 80-member international
clinical trials group, recognized as a leading influence in the
field of pediatric BMT.
Pulsipher is a highly accomplished NIH-funded investigator whose
major areas of research focus in BMT include innovative approaches
for children with acute lymphoblastic leukemia and bone marrow
failure conditions, reduced toxicity regimens and donor safety. He
is currently principal or co-principal investigator on six
national, multi-center studies and a co-investigator on multiple
additional clinical trials. Dr. Pulsipher has authored more than
130 articles in peer-reviewed journals including Journal of
Clinical Investigation, Blood, and Nature Genetics. He has also
written five book chapters and presented widely at national and
international conferences.
Board-certified by the American Board of Pediatrics and its
Sub-board of Pediatric Hematology-Oncology, he is a Specialty
Fellow of the American Academy of Pediatrics and a member of the
American Society of Clinical Oncology, the American Society of
Hematology, the American Society of Pediatric Hematology/Oncology,
the American Society of Blood and Marrow Transplantation, and the
World Marrow Donor Association. He serves on the editorial boards
of Biology of Blood and Marrow Transplantation, Bone Marrow
Transplantation, and Pediatric Blood and Cancer. He is also a
member of the National Cancer Institute’s Pediatric Data Query
Editorial Board.
About Children’s Hospital Los Angeles
Children’s Hospital Los Angeles has been named the best
children’s hospital in California and among the top 10 in the
nation for clinical excellence with its selection to the
prestigious U.S. News & World Report Honor Roll. Children’s
Hospital is home to The Saban Research Institute, one of the
largest and most productive pediatric research facilities in the
United States. Children’s Hospital is also one of America’s premier
teaching hospitals through its affiliation since 1932 with the Keck
School of Medicine of the University of Southern California.
For more information, visit CHLA.org. Follow us on Twitter,
Facebook, YouTube and LinkedIn, or visit our blog:
www.WeTreatKidsBetter.org.
’
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150630006644/en/
Children’s Hospital Los AngelesDebra Kain323-361-7628 or
323-361-1812dkain@chla.usc.edu